These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18827915)

  • 1. Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.
    Pimenta E; Oparil S
    Vasc Health Risk Manag; 2008; 4(3):653-64. PubMed ID: 18827915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olmesartan/Amlodipine: combination therapy for the treatment of hypertension [corrected].
    Pimenta E
    Adv Ther; 2009 Jan; 26(1):1-11. PubMed ID: 19129998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice.
    Bramlage P; Wolf WP; Stuhr T; Fronk EM; Erdlenbruch W; Ketelhut R; Schmieder RE
    Vasc Health Risk Manag; 2010 Sep; 6():803-11. PubMed ID: 20859549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Barrios V; Brommer P; Haag U; Calderón A; Escobar C
    Clin Drug Investig; 2009; 29(7):427-439. PubMed ID: 19499960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
    Volpe M; Miele C; Haag U
    Clin Drug Investig; 2009; 29(6):381-91. PubMed ID: 19432498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olmesartan/amlodipine: a review of its use in the management of hypertension.
    Kreutz R
    Vasc Health Risk Manag; 2011; 7():183-92. PubMed ID: 21490944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.
    Volpe M; de la Sierra A; Kreutz R; Laurent S; Manolis AJ
    High Blood Press Cardiovasc Prev; 2014 Jun; 21(2):137-47. PubMed ID: 24532183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of olmesartan in combination therapy in blood pressure control and vascular function.
    Ferrario CM; Smith RD
    Vasc Health Risk Manag; 2010 Sep; 6():701-9. PubMed ID: 20859541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A titrate-to-goal study of switching patients uncontrolled on antihypertensive monotherapy to fixed-dose combinations of amlodipine and olmesartan medoxomil ± hydrochlorothiazide.
    Weir MR; Hsueh WA; Nesbitt SD; Littlejohn TJ; Graff A; Shojaee A; Waverczak WF; Qian C; Jones CJ; Neutel JM
    J Clin Hypertens (Greenwich); 2011 Jun; 13(6):404-12. PubMed ID: 21649839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE; Scott LJ
    Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daytime systolic ambulatory blood pressure with a direct switch between candesartan monotherapy and the fixed-dose combination olmesartan/amlodipine in patients with uncontrolled essential hypertension (SEVICONTROL-1).
    Zemmrich C; Lüders S; Gansz A; Sturm CD; Fimmers R; Nadal J; Schmieder RE; Schrader J; Bramlage P
    J Clin Hypertens (Greenwich); 2013 Nov; 15(11):815-9. PubMed ID: 24102831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
    da Silva PM
    Clin Drug Investig; 2010; 30(9):625-41. PubMed ID: 20626210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension.
    Miyashita Y; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohira M; Oyama T; Shirai K
    J Atheroscler Thromb; 2009 Oct; 16(5):621-6. PubMed ID: 19907103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
    Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
    Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.
    Ram CV
    Curr Med Res Opin; 2009 Jan; 25(1):177-85. PubMed ID: 19210150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
    Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
    Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of olmesartan/amlodipine combination therapy in patients with mild-to-severe hypertension: focus on 24-h blood pressure control.
    Parati G; Ochoa JE; Ramos C; Hoshide S; Lonati L; Bilo G
    Ther Adv Cardiovasc Dis; 2010 Oct; 4(5):301-13. PubMed ID: 20921092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.